Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheuk-Man Yu

Showing results (111-120 of 320) with videos related to

Pageof 32
Sort By:
International Journal of Cardiology|April 12, 2011
New pulmonary vein Doppler echocardiographic index predicts significant interatrial shunting in secundum atrial septal defectYat-Yin Lam, Fang Fang, Gabriel Wai-Kwok Yip, et al.
International Journal of Cardiology|June 21, 2016
Prognostic value of acoustic cardiography in patients with chronic heart failureShang Wang, Ming Liu, Fang Fang, et al.
European Journal of Pharmacology|March 5, 2011
A novel anti-fibrotic agent, baicalein, for the treatment of myocardial fibrosis in spontaneously hypertensive ratsEbenezer K C Kong, Shan Yu, John E Sanderson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2014
miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signalingYang Zhang, Xiao-Ru Huang, Li-Hua Wei, et al.
Cardiology Journal|July 25, 2008
Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complexVinodh Jeevanantham, Wojciech Zareba, Sankar Navaneethan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2026
Retraction Notice to: miR-29b as a Therapeutic Agent for Angiotensin II-induced Cardiac Fibrosis by Targeting TGF-β/ Smad3 signalingYang Zhang, Xiao-Ru Huang, Li-Hua Wei, et al.
Journal of Geriatric Cardiology : JGC|January 21, 2016
Current understanding of coronary artery calcificationWei Liu, Yue Zhang, Cheuk-Man Yu, et al.
BMC Cardiovascular Disorders|October 9, 2015
How low should we target the LDL goal to improve survival for acute coronary syndrome patients in Hong Kong?Vivian W Lee, Raymond Y Chau, Herich Y Cheung, et al.
Drug Discovery Today|July 6, 2010
Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseasesMing Dong, Bryan P Yan, James K Liao, et al.
American Heart Journal|January 21, 2014
Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: a multinational 10-year experience: data from the Multicenter International CRT StudyMaurizio Gasparini, Christophe Leclercq, Cheuk-Man Yu, et al.
Pageof 32

Showing results (111-120 of 320) with videos related to

Sort By:
Pageof 32
International Journal of Cardiology|April 12, 2011
New pulmonary vein Doppler echocardiographic index predicts significant interatrial shunting in secundum atrial septal defectYat-Yin Lam, Fang Fang, Gabriel Wai-Kwok Yip, et al.
International Journal of Cardiology|June 21, 2016
Prognostic value of acoustic cardiography in patients with chronic heart failureShang Wang, Ming Liu, Fang Fang, et al.
European Journal of Pharmacology|March 5, 2011
A novel anti-fibrotic agent, baicalein, for the treatment of myocardial fibrosis in spontaneously hypertensive ratsEbenezer K C Kong, Shan Yu, John E Sanderson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2014
miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signalingYang Zhang, Xiao-Ru Huang, Li-Hua Wei, et al.
Cardiology Journal|July 25, 2008
Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complexVinodh Jeevanantham, Wojciech Zareba, Sankar Navaneethan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2026
Retraction Notice to: miR-29b as a Therapeutic Agent for Angiotensin II-induced Cardiac Fibrosis by Targeting TGF-β/ Smad3 signalingYang Zhang, Xiao-Ru Huang, Li-Hua Wei, et al.
Journal of Geriatric Cardiology : JGC|January 21, 2016
Current understanding of coronary artery calcificationWei Liu, Yue Zhang, Cheuk-Man Yu, et al.
BMC Cardiovascular Disorders|October 9, 2015
How low should we target the LDL goal to improve survival for acute coronary syndrome patients in Hong Kong?Vivian W Lee, Raymond Y Chau, Herich Y Cheung, et al.
Drug Discovery Today|July 6, 2010
Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseasesMing Dong, Bryan P Yan, James K Liao, et al.
American Heart Journal|January 21, 2014
Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: a multinational 10-year experience: data from the Multicenter International CRT StudyMaurizio Gasparini, Christophe Leclercq, Cheuk-Man Yu, et al.
Pageof 32